This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Tocris Bioscience
product type :
chemical
product name :
AG 490
catalog :
0414/50
quantity :
50 mg
price :
556 USD
citations: 14
| Reference |
|---|
Gross E, Hsu A, Gross G. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta. Am J Physiol Heart Circ Physiol. 2006;291:H827-34 pubmed
|
Bellik L, Vinci M, Filippi S, Ledda F, Parenti A. Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia. Br J Pharmacol. 2005;146:568-75 pubmed
|
product information
brand :
Tocris
master code :
414
SKU :
0414/50
product name :
AG 490
description :
EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor
target :
EGF Receptor Inhibitors
category :
Small Molecules
unit size :
50 mg
purity :
99%
observed molecular weight :
294.31
url print :
?utm_source=distributor&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules
details of functionality :
AG 490 is a selective inhibitor of EGF receptor tyrosine kinase (IC50 values are 2 and 13.5 u M for EGFR and ErbB2 respectively). Inhibitor of JAK2, JAK3/STAT, JAK3/AP-1 and JAK3/MAPK pathways and potently inhibits cytokine-independent cell growth in vitro and tumor cell invasion in vivo .
catalog number base :
414
extended description :
EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor
chemical name text :
(E)-2-Cyano-3-(3,4-dihydrophenyl)-N-(phenylmethyl)-2-propenamide
formula :
C 17 H 14 N 2 O 3
formula text :
C17H14N2O3
cas num :
133550-30-8
USD 2021 :
520
USD 2022 :
556 USD
product details :
EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor
atl names :
Tyrphostin AG 490
storage :
Store at RT
company information

Tocris Bioscience
The Watkins Building
Atlantic Road
Avonmouth, Bristol
BS11 9QD
Atlantic Road
Avonmouth, Bristol
BS11 9QD
info@bio-techne.com
https://www.tocris.com800-343-7475
headquarters: UK
questions and comments
